Low birth weight is related to stunting incidents: indonesian nutrition status survey data analysis

The problem of stunting in Indonesia is classified as chronic. In 2022, the prevalence of stunting in Indonesia was 21.6%, down from 24.4% in 2021. However, the percentage of stunting above 20% is still high and far from the WHO target. This study aimed to determine the relationship between birth weight and the incidence of stunting in toddlers in Indonesia. The research design was cross-sectional, using Indonesian Nutrition Status Survey Data in 2021 obtained from the Indonesian Health Ministry. The sample of this study was 20808 data. The data analysis techniques used were univariate, bivariate, and multivariate analysis. The results show that the variables that influence the incidence of stunting in toddlers in Indonesia are birth weight category (p=0.000; OR=2.720; CI=2.420-3.080), child age (p=0.000; OR=2.617; CI=2.401-2.854), gender of toddlers (p=0.000; OR=1.439; CI=1.338-1.547), mother's education level (p=0.000; OR=1.329; CI=1.230-1.436), JKN ownership (p=0.026; OR=1.098; CI=1.011-1.191), mother's employment status (p=0.013; OR=0.904; CI= 0.834-0.979), age of starting solids (p=0.000; OR=0.824; CI=0.767-0.886). This study found that birth weight was the most influential factor in the incidence of stunting. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This study was funded by School of Medicine Universitas Negeri Semarang ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data produced in the present study are available upon reasonable request to the authors